CognitMarket market news, portfolio research, and investor insights

Your market command center

Research the market. Understand your portfolio. Act with confidence.

Turn market-moving news into a focused daily view of the companies, portfolios, and ideas you care about.

Login
Create my free account
Free to start · No card required

Top Stories

The developments most likely to shape today’s market conversation.
Factbox-DoorDash delivers latest deal as industry consolidation gathers pace
Company News

Factbox-DoorDash delivers latest deal as industry consolidation gathers pace

INVESTING.COM

Oct 29 (Reuters) - Doordash said on Thursday it would buy US grocery delivery rival Instacart in a deal valued at about $17 billion.

Intensifying competition amid cautious consumer spending, slower growth since the pandemic boom and mounting regulatory and labor-related costs are driving a consolidation in the delivery industry.

In July, Uber agreed to buy Germany’s Delivery Hero to create the largest food-delivery group outside China.

Here are some of the companies that have announced buyouts since 2020:

Year Buyer Target Deal value Link

2026 DoorDash Instacart $17

billion

2026 Uber Delivery $14.8

Hero billion

2025 DoorDash Deliveroo $3.85

billion

2025 Prosus Just Eat $4.3

Takeaway.c billion

om

2025 Wonder Grubhub $650

million

including

debt

2022 DoorDash Wolt $3.5

billion

2021 Just Eat Grubhub $7.3

Takeaway.c billion

om

2020 Uber Postmates $2.65

billion

ProPicks AI re-scores DHER every month against thousands of alternatives on 100+ financial metrics, then bu

Intel stock plunges 16% as chipmaker blames PC slowdown for weak guidance
Company News

Intel stock plunges 16% as chipmaker blames PC slowdown for weak guidance

REDDIT.COM

Intel shares plummeted in extended trading on Thursday after the chipmaker issued a weak fourth-quarter forecast, citing continued softness in the global PC market.

Here’s how the company did in the third quarter, compared with estimates from analysts polled by LSEG:

Earnings per share: 52 cents adjusted vs. 40 cents expected

Revenue: $16.51 billion vs. $16.5 billion expected

Revenue climbed 21% from $13.7 billion a year earlier, the company said in a press release.

However, revenue in Intel’s client computing and physical AI group fell 5% from the same quarter a year ago to $8.1 billion, missing estimates, even as data center and AI revenue jumped 78% to $7.3 billion.

Global PC shipments declined 4% in the second quarter from a year earlier due to soaring costs for memory and other components, according to Counterpoint Research.

For the current quarter, Intel said it expects adjusted earnings per share of 25 cents on revenue between $15 billion and $16 billion. Analysts were ex

Congratulations to those that had positions in ADT.
Company News

Congratulations to those that had positions in ADT.

REDDIT.COM

Home security giant ADT to be acquired for $7.6 billion in all-cash deal

The greater than 35% free cash flow yield they traded at for the past month, for a company with stable revenue (slow growth, but lower than the inflation rate) wasn't going to be ignored by market participants indefinitely.

I've been watching them for most of the past year, awaiting an even better deal. I was wrong to not nibble.

Eli Lilly blows past estimates, hikes sales outlook as Zepbound and Mounjaro demand surge again
Company News

Eli Lilly blows past estimates, hikes sales outlook as Zepbound and Mounjaro demand surge again

CNBC.COM

In this article

Eli Lilly on Thursday reported third-quarter earnings and revenue that blew past estimates and hiked its full-year sales outlook, as demand for its blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro soared again.

Despite that strength, sales of its new GLP-1 obesity pill Foundayo, which launched in the U.S. in April, were under Wall Street’s expectations for the quarter.

The pharmaceutical giant now expects 2026 revenue to come in between $91 billion and $92 billion, up from a previous guidance of $85 billion to $87 billion.

Lilly projects its full-year adjusted earnings will be between $35 and $36 per share, which compares with a previous outlook of $35.50 to $36.50 per share. The company said it raised the underlying profit guidance by $4.07 per share at the midpoint, but noted that it is offset by $4.57 per share in charges tied to deals in the quarter.

The company’s shares rose about 4% in premarket trading.

Tune in at 9 a.m. ET as Eli Lilly

ADT stock spikes 34% on $7.6 billion takeover deal by Josh Kushner’s Thrive
Company News

ADT stock spikes 34% on $7.6 billion takeover deal by Josh Kushner’s Thrive

STREETINSIDER.COM

Investing.com -- Shares in home security firm ADT soared about 34% to their highest level since December 2022 on Thursday, after the company agreed to be acquired by Josh Kushner’s venture capital firm Thrive Holdings in an all-cash transaction valuing the company at approximately $7.6 billion.

Under the terms of the agreement, ADT stockholders will receive $10.00 per share in cash, representing a 45.6% premium to ADT’s closing share price of $6.87 on October 27, 2026. The deal values ADT at $15.3 billion in enterprise value.

The transaction combines ADT’s security expertise, technology and nationwide network of professionals with Thrive Holdings’ long-term capital and engineering capabilities. Upon completion, ADT will become a privately held company.

"ADT is pleased to enter into this transaction, which recognizes the value built by our more than 12,000 employees and delivers an attractive cash premium to our stockholders," said Jim DeVries, Chairman, President and Chief Executive

Earnings call transcript: BioInvent shares plunge on Q3 2026 financing fears
Company News

Earnings call transcript: BioInvent shares plunge on Q3 2026 financing fears

INVESTING.COM

BioInvent International AB said its Q3 2026 sales rose year over year, but the market focused on the company’s financing needs and steep dilution risk, sending the stock down 71.5% to $5.90 from a previous close of $20.70. The Swedish biotech reported net sales of SEK 10.8 million for the quarter, up from SEK 3.3 million a year earlier, while operating costs eased to SEK 131 million from SEK 137 million. The company also said its cash balance of SEK 225 million would fund operations only into the latter part of Q1 2027 unless it completes a planned rights issue.

BioInvent remains a clinical-stage biotech company with limited product revenue and heavy research spending. The quarter showed a modest improvement in sales and a small decline in operating costs, but the broader nine-month picture was weaker because 2025 included a large one-time payment tied to mezagitamab rights.

For the January-September period, net sales fell to SEK 37 million from SEK 224 million a year earlier. The co

1 / 6

For You

Personalize this briefing around the investments you care about.

Follow the market through your own lens.

Create a free account to bring watchlist updates, portfolios, and Autopilot status into this briefing.

Trending now

Top portfolios

From the Community

Recent questions, research, and investing ideas from members.

Crypto exchange Binance is investigating a 'potential security issue' after stablecoin issuers Circle and Tether froze a combined $2.54 billion in funds linked to the incident .

Key details:

  • Binance states user funds are 'completely safe' and trading on Binance Alpha is temporarily suspended .
  • Arkham Intelligence identified nearly $6 billion in digital assets across 55 wallets potentially linked to the exploit .
  • This event highlights ongoing security risks in the crypto ecosystem, with past exploits exceeding $1.5 billion .
Binance ‘potential security issue’ sees $2.54 billion frozen by the likes of Circle, Tether

Binance ‘potential security issue’ sees $2.54 billion frozen by the likes of Circle, Tether

CNBC.COMOct 29, 11:56 PM UTC
0

Dexcom (NASDAQ:DXCM) reported Q3 2026 results exceeding expectations, with revenue of $1.344 billion and non-GAAP EPS of $0.73. The glucose monitoring company raised its full-year guidance across multiple metrics, driven by:

  • Gross margins reaching a multi-year high of 65.1%.
  • Robust 14% U.S. revenue growth, offsetting slower international expansion.
  • Publication of the CONNECT study in NEJM, showcasing strong A1C results.

Shares rose 1.73% after-hours as investors reacted positively to improved profitability and steady execution.

Dexcom Q3 2026 slides: margins hit multi-year high, guidance raised

Dexcom Q3 2026 slides: margins hit multi-year high, guidance raised

INVESTING.COMOct 29, 9:52 PM UTC
2

Home security firm ADT (ADT) stock surged 34% after agreeing to be acquired by Josh Kushner’s Thrive Holdings in an all-cash transaction valued at approximately $7.6 billion. Stockholders will receive $10.00 per share, a 45.6% premium to ADT’s closing price on Oct 27 . The deal, which will take ADT private, is expected to close in Q1 2027, subject to shareholder and antitrust approval .

ADT stock spikes 34% on $7.6 billion takeover deal by Josh Kushner’s Thrive

ADT stock spikes 34% on $7.6 billion takeover deal by Josh Kushner’s Thrive

STREETINSIDER.COMOct 29, 3:04 PM UTC
2

Concerns over AI infrastructure spending and monetization are escalating. Alphabet (GOOGL) shares plunged over 11% after disappointing search ad results and a surge in cash burn due to AI-related spending . While Mizuho recommends buying the dip, citing Cloud upside, they acknowledge AI Mode monetization lags traditional search .

Further fueling worries, Microsoft's capital expenditure report missed consensus, interpreted as potential pressure on hyperscaler spending for external AI compute . This sent neocloud providers like Nebius (NBIS) and CoreWeave (CRWV) lower, highlighting the debt-heavy nature and financing risks in the sector . Steve Eisman warns the AI trade is nearing a 'tipping point' due to capital efficiency issues and monetization challenges .

Jim Cramer’s top 10 things to watch in the stock market Thursday

Jim Cramer’s top 10 things to watch in the stock market Thursday

CNBC.COMOct 29, 1:13 PM UTC
Wall St set for lower open as Alphabet results reignite AI spending fears

Wall St set for lower open as Alphabet results reignite AI spending fears

INVESTING.COMOct 29, 1:19 PM UTC
Analyst explains why you should buy the pullback in Google shares

Analyst explains why you should buy the pullback in Google shares

INVESTING.COMOct 29, 11:37 AM UTC
Why is Nebius stock sliding today?

Why is Nebius stock sliding today?

INVESTING.COMOct 29, 2:30 PM UTC
NBIS vs CRWV: growth quality against valuation and leverage

NBIS vs CRWV: growth quality against valuation and leverage

INVESTING.COMOct 29, 2:50 PM UTC
Aschenbrenner seeks Fluidstack investment at $40 billion valuation - Bloomberg

Aschenbrenner seeks Fluidstack investment at $40 billion valuation - Bloomberg

INVESTING.COMOct 29, 3:51 PM UTC
Steve Eisman gets more conservative with portfolio as AI trade nears ‘tipping point’

Steve Eisman gets more conservative with portfolio as AI trade nears ‘tipping point’

CNBC.COMOct 29, 2:15 PM UTC
1 / 7
2

Mega-cap tech earnings show a clear divergence: Alphabet (GOOGL) shares plunged 11.5% premarket after disappointing search ad results and surging AI-related spending raised concerns about profitability . In contrast, Microsoft (MSFT) climbed 1.8% on a strong cash flow beat and robust cloud growth .

Key takeaways:

  • Alphabet (GOOGL): Missed on most lines, with search growth slowing and AI monetization at a lower rate than traditional search. AI-related spending accelerated, impacting cash burn .
  • Microsoft (MSFT): Delivered strong Azure growth (48% YoY) and maintained spending discipline, leading to positive free cash flow .

This highlights investor scrutiny on AI spending efficiency and the varying impacts on tech giants' bottom lines.

Wall St set for lower open as Alphabet results reignite AI spending fears

Wall St set for lower open as Alphabet results reignite AI spending fears

INVESTING.COMOct 29, 1:19 PM UTC
Jim Cramer’s top 10 things to watch in the stock market Thursday

Jim Cramer’s top 10 things to watch in the stock market Thursday

CNBC.COMOct 29, 1:13 PM UTC
1 / 2
1

Mega-cap tech earnings are driving market sentiment with significant divergence. Alphabet (GOOGL) shares plunged 10% after hours due to an EPS miss and a negative $9 billion cash flow, primarily attributed to surging AI infrastructure capital expenditures . This raises concerns about the funding capacity for hyperscalers in the AI race .

Conversely, Microsoft (MSFT) gained 2.9% after reporting nearly $19 billion in free cash flow, rewarding its ability to self-fund capex . Samsung (KS:005930) also fell 5% despite record earnings, as investors focused on semiconductor profit expectations and uncertainty over shareholder returns amidst high AI-driven memory demand and capex projections .

Nasdaq futures are down over 1% as markets await Amazon and Intel earnings .

Morning Bid: In the AI alphabet, cash is king

Morning Bid: In the AI alphabet, cash is king

INVESTING.COMOct 29, 5:36 AM UTC
Asia stocks mixed as Alphabet, Samsung results disappoint; more tech earnings loom

Asia stocks mixed as Alphabet, Samsung results disappoint; more tech earnings loom

INVESTING.COMOct 29, 7:38 AM UTC
1 / 2
3

SK Hynix (HXSCL) reported blockbuster Q3 earnings, with revenue topping estimates by 6% and gross margins at 85.7%. The memory giant projects mid-20% shipment growth this quarter and is effectively sold out through 2029 due to strong AI data center demand . This upbeat outlook lifted other chipmakers, including Micron (+6%), Arm (+4%), and AMD (+3%) .

FormFactor (FORM) also beat Q3 estimates, citing broad demand from AI infrastructure, advanced packaging, and photonics, marking its fourth consecutive quarter of record sales . The company's strong execution and improved profitability profile have led analysts to revise earnings estimates upward .

This signals continued robust demand for AI-related hardware, despite broader market skepticism on data center spending .

Jim Cramer sees major implications from SK Hynix’s home-run quarter

Jim Cramer sees major implications from SK Hynix’s home-run quarter

CNBC.COMOct 28, 11:00 PM UTC
Earnings call transcript: FormFactor beats Q3 2026 estimates, stock slips after hours

Earnings call transcript: FormFactor beats Q3 2026 estimates, stock slips after hours

INVESTING.COMOct 28, 9:33 PM UTC
1 / 2
2

Alphabet A (GOOGL) reported Q3 EPS of $2.12, missing analyst estimates of $3.02 by $0.90. Revenue came in at $127.6B, slightly topping the consensus of $127.22B . The stock closed down -8.77% in the last 3 months, but is up 18.33% in the last 12 months .

Ahead of the earnings release, options traders showed contrasting views, with an implied move of nearly 6% for the stock. One bullish trade targeted a 13% jump to $365, while a bearish 3x1 put diagonal collected $1.9M, betting on a 9% move lower through mid-January .

Alphabet A earnings missed by $0.90, revenue topped estimates

Alphabet A earnings missed by $0.90, revenue topped estimates

INVESTING.COMOct 28, 8:09 PM UTC
Watch Live: Options traders break down a massive Alphabet trade into earnings

Watch Live: Options traders break down a massive Alphabet trade into earnings

CNBC.COMOct 28, 5:56 PM UTC
1 / 2
1

The US Department of Justice is reportedly scrutinizing Nvidia's (NVDA) $12.93 billion acquisition of open-source AI platform Hugging Face for potential antitrust implications . Inquiries focus on how the deal could affect competition in artificial intelligence and whether Nvidia has exerted pressure on customers. This comes amidst a broader, years-long investigation into Nvidia's conduct. The acquisition is expected to close in H1 2027. Any action by the DOJ could challenge Nvidia's AI investment and acquisition strategy, potentially impacting the broader chip industry.

Exclusive-US DOJ is inquiring about Nvidia’s purchase of Hugging Face, sources say

Exclusive-US DOJ is inquiring about Nvidia’s purchase of Hugging Face, sources say

INVESTING.COMOct 28, 6:36 PM UTC
2

The 'Magnificent Seven' stocks are no longer trading as a cohesive block, with their average 60-day correlation hitting a decade low . This divergence challenges investors to focus on individual company fundamentals and AI exposure rather than treating the group as a single trade.

Key points:

  • MAGS ETF is up 7% YTD, lagging the S&P 500's 12% gain .
  • Tesla and Meta are down YTD, while Nvidia and Apple outperform the S&P 500 .
  • Upcoming earnings from Microsoft, Alphabet (today), and Amazon (tomorrow) will further test individual performance .

This shift suggests a more granular approach is needed for mega-cap tech investing, moving away from broad group-based strategies .

The ‘Magnificent Seven’ is no more. Time to pick winners and losers as group’s correlation breaks down

The ‘Magnificent Seven’ is no more. Time to pick winners and losers as group’s correlation breaks down

CNBC.COMOct 28, 1:09 PM UTC
1